Q3 FY26 Results: Revenue Down 8% YoY, PAT Falls 29% to Rs 198 mn
LXCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q3 FY26 standalone revenue at Rs 7,069 mn, down 8% YoY from Rs 7,679 mn. Q3 PAT fell 29% to Rs 198 mn from Rs 278 mn. For 9M, revenue Rs 20,852 mn vs Rs 22,303 mn and PAT Rs 567 mn vs Rs 895 mn. Results include one-off gains of Rs 407 mn electricity liability reversal and Rs 234 mn GST incentive. Depreciation method changed to straight line. Comparatives restated for YFCPL amalgamation. Board re-appointed Dr Rajiv Banavali as Independent Director for 2 years.
Revenue and earnings declined YoY despite one-off gains boosting reported numbers. Underlying demand weak. Comparatives restated for YFCPL merger.